Page last updated: 2024-08-23

paroxetine and fluvoxamine

paroxetine has been researched along with fluvoxamine in 243 studies

Research

Studies (243)

TimeframeStudies, this research(%)All Research%
pre-19902 (0.82)18.7374
1990's69 (28.40)18.2507
2000's106 (43.62)29.6817
2010's55 (22.63)24.3611
2020's11 (4.53)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J1
Dansette, PM; Fontana, E; Poli, SM1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F1
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bojarski, AJ; Bugno, R; Duszyńska, B; Hogendorf, A; Hogendorf, AS; Kurczab, R; Lenda, T; Pietruś, W; Satała, G; Staroń, J; Wantuch, A; Warszycki, D1
Crewe, HK; Haddock, RE; Lennard, MS; Tucker, GT; Woods, FR1
Grimsley, SR; Jann, MW1
DeVane, CL1
Johnson, AM; Tulloch, IF1
Goodman, WK; McDougle, CJ; Price, LH1
Baldwin, D; Bullock, T; Montgomery, D; Montgomery, S1
Fuller, RW1
Asberg, M; Eriksson, B; Mårtensson, B; Träskman-Bendz, L; Wägner, A1
Perez, J; Popoli, M; Racagni, G; Smeraldi, E; Vocaturo, C1
Baumann, P; Rochat, B1
Anelli, M; Caccia, S; Codegoni, AM; Fracasso, C; Garattini, S1
Finley, PR1
Hyttel, J; Sánchez, C1
Court, MH; Duan, SX; Greenblatt, DJ; Harmatz, JS; Shader, RI; von Moltke, LL1
Gray, AM; Rafieian-Kopaei, M; Sewell, RD; Spencer, PS1
Rechlin, T1
Feighner, JP1
Brøsen, K1
LaBranche, S1
Joffe, RT; Levitt, AJ; Sokolov, ST; Young, LT1
Bastani, AJ; Bastani, JB; Troester, MM1
Newhouse, PA1
Lazowick, AL; Levin, GM1
Knowles, SR; Liu, BA; Mittmann, N; Shear, NH1
Harvey, AT; Preskorn, SH2
Brøsen, K; Gram, LF; Jeppesen, U; Loft, S; Poulsen, HE; Vistisen, K1
Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH1
Egashira, T; Goto, S; Takayama, F; Wada, Y; Yamanaka, Y1
Bell, CJ; Coupland, NJ; Potokar, JP1
Leo, RJ1
Harnett-Sheehan, K; Sheehan, DV1
de Vet, HC; Hartmans, M; Honig, A; Menting, JE; Rozendaal, N; van Praag, HM; Verhey, FR1
Kurz, X; Ottervanger, JP; Roisin, T; Stricker, BH; Van Ermen, AM1
Preskorn, SH1
Baumann, P; Eap, CB1
MacKay, AV; Price, JS; Waller, PC; Wood, SM1
Meier, E; Sánchez, C1
Earley, B; Faherty, CJ; Leonard, BE1
Black, KJ; Sheline, YI1
Feiger, A; Kiev, A1
Tielens, JA1
Ahern, D; Ball, SE; Kao, J; Scatina, J1
Di Mascio, M; Esposito, E1
Bellodi, L; Bianchi, L; Mundo, E1
Mitchell, S; Tracy, KA; Zajecka, J1
Bousoño, M; Calcedo, A; Carrasco, JL; Ciudad, J; Daniel, E; De la Gandara, J; Derecho, J; Franco, M; Gomez, MJ; Izquierdo, JA; Ledesma, A; Llorca, G; Macias, JA; Martin, T; Montejo-González, AL; Perez, V; Sanchez, JM; Sanchez, S; Vicens, E1
Richelson, E1
Gorman, JM1
Anghelescu, I; Härter, S; Hiemke, C; Szegedi, A; Weigmann, H; Wetzel, H; Wiesner, J1
Brochu, J; Cook, L; Feldkamp, M; Koren, G; Kulin, NA; Matsui, D; Ormond, K; Pastuszak, A; Rieder, M; Sage, SR; Schick-Boschetto, B; Spivey, G; Stein-Schechman, AK1
Herrmann, N; Kalow, W; Naranjo, CA; Ozdemir, V; Reed, K; Sellers, EM; Shulman, RW1
Grush, LR1
Belpaire, FM; Brøsen, K; Rasmussen, BB; Temmerman, A; Wijnant, P1
Hengeveld, MW; Olivier, B; Waldinger, MD; Zwinderman, AH1
Bourin, M; Redrobe, JP1
Di Giovanni, G; Di Mascio, M; Di Matteo, V; Esposito, E; Prisco, S1
Barbey, JT; Roose, SP1
Gram, LF1
Stahl, SM1
Anand, VS; Dewan, MJ1
Alvarez, E; Artigas, F; Pérez, V; Puigdemont, D; Soler, J1
Alfaro, CL; Ereshefsky, L; Lam, YW; Simpson, J1
De Vry, J; Maurel, S; Schreiber, R1
Carleborg, L; Hägg, S; Ohman, R; Spigset, O1
Sheehan, DV1
Bakker, A1
Benmansour, S; Cecchi, M; Frazer, A; Gerhardt, GA; Gould, GG; Javors, MA; Morilak, DA1
Baker, F; Day, A; Gath, DH; Mynors-Wallis, LM1
Härtter, S; Hiemke, C1
Gentilini, G; Lopez-Silva, S; Lucca, A; Soldarini, A1
Freisleder, FJ; Mayer-Rosa, J; Rüth, U; Schlamp, D1
Baier, D; Kohnen, R; Philipp, M; Tiller, JW1
Bongiorno, F; Franchini, L; Rossini, D; Smeraldi, E; Spagnolo, C; Zanardi, R1
Court, MH; Duan, SX; Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL1
Consogno, E; Dorigo, C; Popoli, M; Racagni, G1
Vallée, JP1
Barnett, W; Fritzsche, M; Richter, P; Sattler, HD; von Turner, A1
Fitzgerald, F; Glod, CA; Lynch, A1
Dewa, CS; Goering, P; Hoch, JS1
Gersh, T; Hobson, JA; Pace-Schott, EF; Salzman, C; Silvestri, R; Stickgold, R2
Bergsholm, YK; Bøhler, E; Nordeng, H; Spigset, O1
Altshuler, L; Brunhuber, MV; Fukuchi, A; Hendrick, V; Wertheimer, A; Widawski, M1
Kuboki, T1
Camarero, J; Colado, MI; Esteban, B; Green, AR; Peter, MJ; Sanchez, V1
Bellodi, L; Cavallini, MC; Cavedini, P; Diaferia, G; Erzegovesi, S; Locatelli, M1
Cusin, C; Lattuada, E; Lilli, R; Lorenzi, C; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R2
Buitelaar, JK; Lahuis, B; Vorstman, J1
Mynors-Wallis, LM; Thornett, AM1
Coolen, LM; Olivier, B; Pattij, T; van De Plas, A; van Oorschot, R; Veening, JG; Waldinger, MD1
De Groote, L; Olivier, B; Westenberg, HG1
Cullen, N; Lexell, J; Zafonte, RD1
Droogmans, G; Maertens, C; Nilius, B; Verbesselt, R1
Alfaro, CL; Ereshefsky, L; Gaedigk, A; Lam, YW; Simpson, J1
Fujishiro, J; Imanishi, T; Onozawa, K; Tsushima, M1
Entsuah, R; Rudolph, RL; Stahl, SM1
Anderson, TA; Dobscha, SK; Hauser, P; Hoffman, WF; Snodgrass, LS; Turner, EH; Winterbottom, LM1
Denys, D; van Megen, HJ; Westenberg, HG1
Koyama, T; Suzuki, K1
Koga, M1
Ohmori, T; Sumitani, S1
Kiriike, N1
Arita, S; Morishita, S4
Murakami, N; Nagai, T; Narita, N; Sakuta, R; Tazoe, M1
Broocks, A; Hohagen, F; Kordon, A1
Masuda, Y; Shimizu, T1
Fujii, Y; Iwamura, Y; Kamei, C1
Almarza, E; Martínez, MA; Sánchez de la Torre, C1
Ben-Amir, E; Doljansky, J; Flaisher, S; Joel, D1
Artioli, P; Cusin, C; Dotoli, D; Rossini, D; Serretti, A; Zanardi, R1
Eichner, SF; Jones, JR; Moore, ML1
Imanishi, T; Kojima, M; Nagase, K; Tatebayashi, T; Yamauchi, M1
Casciano, R; Chen, J; Geissler, EC; Mallick, R; Panish, JM; Trivedi, MH; Wan, GJ1
Armbrust, KL; Black, MC; Henry, TB; Kwon, JW1
Hirano, K; Kagawa, Y; Kimura, R; Maruyama, S; Yamada, S1
Albert, U; Bogetto, F; Maina, G; Salvi, V1
Hashimoto, H; Hirano, K; Kato, Y; Kimura, R; Sugimoto, Y; Uchida, S; Yamada, J; Yamada, S1
Arima, Y; Kubo, C; Ohtani, H; Sawada, Y; Tsujimoto, M1
Cools, AR; de Jong, TR; Olivier, B; Pattij, T; Veening, JG; Waldinger, MD1
Baker, B; Baldini-Rossi, N; Hollander, E; Pallanti, S; Sood, E1
Azuma, J; Fukuda, K; Fukuda, T; Ikenaga, Y; Kato, M; Kinoshita, T; Nobuhara, K; Okugawa, G; Wakeno, M1
Benedetti, F; Colombo, C; Cusin, C; Mandelli, L; Pirovano, A; Serretti, A; Smeraldi, E; Zanardi, R1
Asai, Y; Ichimiya, T; Inoue, M; Koyama, T; Kusumi, I; Sudo, Y; Suhara, T; Takahashi, Y; Takano, A; Yasuno, F1
Cools, AR; de Jong, TR; Olivier, B; Pattij, T; Snaphaan, LJ; Veening, JG; Waldinger, MD1
Fava, M; Mallinckrodt, CH; Martinez, JM; Prakash, A; Watkin, JG; Wohlreich, MM1
Carrasco, JL; Sandner, C1
Arias, B; Catalán, R; Fañanás, L; Gastó, C; Lorenzi, C; Serretti, A1
Imanishi, T; Matsushima, T; Miyara, T; Yamauchi, M1
Azuma, N; Fujii, Y; Kamei, C; Kitazumi, K; Shinomiya, K; Sugimoto, Y; Tokunaga, S1
Abraham, G; Milev, R; Stuart Lawson, J1
Berger, U; Jensen, E; Kallenborn, R; Samuelsen, PJ; Vasskog, T1
Belmaker, RH; Nemets, B; Shapira, B; Trachtenberg, A1
Azuma, J; Fukuda, K; Fukuda, T; Ikenaga, Y; Kato, M; Kinoshita, T; Nobuhara, K; Okugawa, G; Takekita, Y; Wakeno, M; Yamashita, M1
Kobayashi, T; Ohtsuki, K; Onogi, T; Satoh, K; Takano, S1
Bailly, D1
Harada, M; Kubo, H; Ohmori, T; Sumitani, S1
Nakamura, J; Shinkai, K; Toyohira, Y; Tsutsui, M; Ueno, S; Yanagihara, N; Yoshimura, R1
Ahn, SC; Choi, TK; Lee, SH; Lee, YJ; Suh, SY; Yook, KH1
Egashira, N; Fujiwara, M; Harada, S; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Okuno, R; Orito, K1
Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R1
Mitsuya, H; Murata, T; Murayama, J; Takahashi, T; Wada, Y1
Fujisaki, M; Hashimoto, K; Ishii, K; Ishikawa, M; Ishiwata, K; Iyo, M; Kimura, Y; Miyatake, R; Naganawa, M; Oda, K; Sakata, M; Shimizu, E; Shirayama, Y1
Ikenouchi-Sugita, A; Nakamura, J; Yoshimura, R1
Nomura, S; Sato, Y; Shigemura, J; Yoshino, A1
Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME1
Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A1
Ikeda, A; Ueki, M; Ushiroyama, T1
Egawa, T; Ikeda, M; Kataoka, Y; Koga, A; Shuto, H; Sohda, Y; Tominaga, K; Yamauchi, A1
Chihara, K; Hashimoto, K; Ishii, K; Ishikawa, M; Ishiwata, K; Kimura, Y; Naganawa, M; Oda, K; Sakata, M1
Azuma, J; Fukuda, T; Hosoi, Y; Kato, M; Kinoshita, T; Okugawa, G; Serretti, A; Takekita, Y; Wakeno, M1
Ağargün, MY; Aşkin, R; Aydin, A; Beşiroğlu, L; Uğuz, F; Yilmaz, E1
Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R1
Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R1
Abe, H; Ikeda, T; Ishida, Y; Nakamura, T; Naono, R; Nishimori, T; Takeda, R1
Amitani, H; Asakawa, A; Fujimiya, M; Fujitsuka, N; Hayashi, M; Inui, A; Kojima, S; Sameshima, M1
Böckenholt, B; Heuft, G; Luger, TA; Schneider, G; Schürmeyer-Horst, F; Ständer, S; Weishaupt, C1
Andersohn, F; Garbe, E; Schade, R; Suissa, S1
Colombo, C; De Ronchi, D; Kato, M; Kinoshita, T; Okugawa, G; Rossini, D; Serretti, A; Zanardi, R1
Imai, T; Inoue, K; Nagata, K; Tozaki-Saitoh, H; Tsuda, M; Yamashita, T1
Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Ohya, K; Stein, DJ1
Hasegawa, R; Ikeda, K; Karasawa, J; Tamura, K; Yamamoto, H; Yamamoto, T; Yasumoto, S1
Aburakawa, Y; Aizawa, H; Hasebe, N; Kwak, S; Sawada, J; Yamashita, T1
Iwata, N; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Naitoh, H; Nakamura, J; Okochi, T; Okumura, T; Ozaki, N; Tsunoka, T; Yamanouchi, Y; Yoshimura, R1
Brophy, JM; Etminan, M; Mikelberg, FS1
Charles, D; Fava, M; Papakostas, GI1
Dormuth, CR; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS1
Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Stein, DJ1
Dormuth, C; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS1
Kato, M1
Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P1
Mochcovitch, MD; Nardi, AE1
Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M1
Deshpande, A; Ing, A; Rizo, C; Seeman, N1
Bhuiyan, S; Fukunaga, K; Hasegawa, H; Kanai, H; Shioda, N; Tagashira, H1
Boku, S; Inoue, T; Izumi, T; Kakuta, A; Kitaichi, Y; Koyama, T; Nakagawa, S1
Fukui, N; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J1
Dobzhenko, MN; Shchepotin, IB; Zotov, AS1
Fukuo, Y; Inada, T; Iwata, N; Kawashima, K; Kishi, T; Kitajima, T; Kushima, I; Matsunaga, S; Naitoh, H; Nakamura, J; Okochi, T; Ozaki, N; Umene-Nakano, W; Yoshimura, R1
Azuma, J; Fujiwara, T; Hara, S; Hasunuma, T; Higashi, K; Katano, T; Kitahara, S; Koue, T; Kubo, M; Miyatake, M1
Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G1
Nagata, T; Nakajima, T; Teo, AR; van Vliet, I; Yamada, H; Yoshimura, C1
Hotta, Y; Kobayashi, Y; Mitsui-Saitoh, K; Sugimoto, Y; Tagawa, N; Yamada, J; Yamamoto, M1
Fukunaga, K; Tagashira, H1
Akamine, Y; Kaneko, S; Niioka, T; Saruwatari, J; Takashima, A; Uno, T; Yasui-Furukori, N1
Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA1
Gotzlav, Y; Iancu, I; Kertzman, S; Kotler, M; Reznik, I; Vainder, M; Weizman, A1
Azuma, J; Hasegawa, R; Hiratsuka, K; Ishiwata, K; Kato, M; Kinoshita, T; Kurosawa, T; Kurose, K; Nishikawa, J; Nonen, S; Okugawa, G; Saito, Y; Wakeno, M1
Boku, S; Fujisawa, D; Honda, M; Inoue, T; Ishikane, T; Ito, K; Kawamura, K; Koyama, T; Matsubara, R; Ono, Y; Sasaki, K; Shinohara, K; Suzuki, T; Tsuchiya, K1
Hotta, Y; Kobayashi, Y; Mitsui-Saito, K; Sugimoto, Y; Tagawa, N; Yamada, J1
Azuma, J; Kato, M; Kinoshita, T; Nonen, S; Serretti, A; Takekita, Y; Tetsuo, S1
Gorman, DA; Lam, D; Patten, S; Pringsheim, T1
Fukunaga, K; Han, F; Izumi, H; Moriguchi, S; Sakagami, H; Sasaki, Y; Yabuki, Y; Zhang, C1
Hermann, M; Molden, E; Waade, RB1
Azuma, J; Kato, M; Kinoshita, T; Nonen, S; Serretti, A; Takekita, Y; Wakeno, M1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N1
Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D1
Ago, Y; Hasebe, S; Hashimoto, H; Matsuda, T; Nishiyama, S; Oka, S; Takuma, K1
Halling-Sørensen, B; Hansen, CH; Jacobsen, NW; Nellemann, C; Styrishave, B1
Egashira, N; Kuwahara, J; Masuda, S; Ueda, M; Ushio, S; Yamada, T; Zukeyama, N1
Bloch, MH; Freemantle, N; Jakubovski, E; Taylor, MJ; Varigonda, AL1
Li, Y; Lu, X; Tao, C; Yan, W1
Casavant, MJ; Chounthirath, T; Russell, JL; Spiller, HA1
Brekke, M; Molden, E; Skogvoll, E; Spigset, O; Westin, AA1
Araujo, M; Benevent, J; Bondon-Guitton, E; Chebane, L; Durrieu, G; Montastruc, F; Montastruc, JL; Ojero-Senard, A1
Biber, K; Bischofberger, J; Clark, K; Dorner, A; Frase, S; Haug, V; Horn, M; Klugbauer, N; Münzer, P; Nissen, C; Normann, C; Scholliers, J; Seifert, G; Serchov, T; Vo Van, T; von Wolff, G1
Coleman, JA; Gouaux, E1
Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA1
Kato, M; Kinoshita, T; Koshikawa, Y; Nonen, S; Ogata, H; Sunada, N; Takekita, Y; Wakeno, M1
Liao, XM; Si, TM; Su, YA; Wang, Y; Yu, X1
Hui, A1
Chen, L; Feng, X; Huang, C; Shen, X; Wang, J; Xu, T1
Komarov, SD; Severtsev, VV; Vdovin, AS; Vinnikova, MA1
Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Gaynes, BN; Pun, PH; Winkelmayer, WC1
Azoulay, L; Cao, TXD; Fergusson, E; Filliter, C; Montastruc, F; Rej, S; Renoux, C; Yu, OHY1
Bayati, R; Ghaffari Jolfayi, A; Nakhaee, H; Rahmanian, M; Rakhshanderou, S; Zangiabadian, M1
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K1
Kodvanj, I; Trkulja, V1
Cai, W; Jiang, D; Liang, H; Lin, Q; Lin, Y; Wang, Y1
Blakely, RD; Groshan, K; Richelson, E; Tatsumi, M1

Reviews

60 review(s) available for paroxetine and fluvoxamine

ArticleYear
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
    Current drug metabolism, 2005, Volume: 6, Issue:5

    Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic

2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Clinical pharmacy, 1992, Volume: 11, Issue:11

    Topics: 1-Naphthylamine; Depressive Disorder; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1992
Pharmacokinetics of the selective serotonin reuptake inhibitors.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline

1992
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline

1992
Pharmacotherapy of obsessive compulsive disorder.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline

1992
5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
    International clinical psychopharmacology, 1991, Volume: 6 Suppl 3

    Topics: Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Mianserin; Paroxetine; Piperidines; Serotonin Antagonists; Suicide; Suicide Prevention

1991
Biochemical pharmacology of the serotonin system.
    Advances in neurology, 1986, Volume: 43

    Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine

1986
Therapeutic effects of serotonin uptake inhibitors in depression.
    The Journal of clinical psychiatry, 1986, Volume: 47 Suppl

    Topics: 5-Hydroxytryptophan; Alanine; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Propylamines; Serotonin; Serotonin Antagonists; Trazodone; Zimeldine

1986
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
    International clinical psychopharmacology, 1995, Volume: 10 Suppl 1

    Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism

1995
Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    The Annals of pharmacotherapy, 1994, Volume: 28, Issue:12

    Topics: 1-Naphthylamine; Alcoholism; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
[Clinical effects of serotonin reuptake inhibitors--a review].
    Fortschritte der Neurologie-Psychiatrie, 1994, Volume: 62 Suppl 1

    Topics: Depression; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors

1994
The pharmacogenetics of the selective serotonin reuptake inhibitors.
    The Clinical investigator, 1993, Volume: 71, Issue:12

    Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors

1993
[New antidepressive agents].
    L'union medicale du Canada, 1995, Volume: 124, Issue:3

    Topics: 1-Naphthylamine; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Child; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1995
Use of serotonin selective reuptake inhibitors in geriatric depression.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 5

    Topics: 1-Naphthylamine; Age Factors; Aged; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1996, Sep-01, Volume: 155, Issue:5

    Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Female; Fluoxetine; Fluvoxamine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part I.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:4

    Topics: Cytochrome P-450 CYP1A1; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Isoenzymes; Microsomes, Liver; Paroxetine; Selective Serotonin Reuptake Inhibitors

1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
    Drug safety, 1996, Volume: 15, Issue:2

    Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan

1996
Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5

    Topics: 1-Naphthylamine; Animals; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Movement disorders associated with the serotonin selective reuptake inhibitors.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:10

    Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States

1996
The role of SSRIs in panic disorder.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 10

    Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
    Journal of chromatography. B, Biomedical applications, 1996, Nov-08, Volume: 686, Issue:1

    Topics: 1-Naphthylamine; Chromatography; Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:7

    Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

1997
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Journal of sex & marital therapy, 1997,Fall, Volume: 23, Issue:3

    Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires

1997
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
    Mayo Clinic proceedings, 1997, Volume: 72, Issue:9

    Topics: 1-Naphthylamine; Antidepressive Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride

1997
The use of newer antidepressants for panic disorder.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 14

    Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

1997
SSRI safety in overdose.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 15

    Topics: Adult; Child; Citalopram; Drug Overdose; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Poison Control Centers; Selective Serotonin Reuptake Inhibitors; Sertraline; United States

1998
Current concepts in the treatment of panic disorder.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 18

    Topics: Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1999
Pharmacokinetics of selective serotonin reuptake inhibitors.
    Pharmacology & therapeutics, 2000, Volume: 85, Issue:1

    Topics: Citalopram; Clinical Trials as Topic; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2000
Psychopharmacologic treatment of adolescent depression.
    Archives of psychiatric nursing, 2001, Volume: 15, Issue:1

    Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride

2001
[Early internal treatment of mild depression].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:8

    Topics: Depression; Fluvoxamine; Health Knowledge, Attitudes, Practice; Humans; Paroxetine; Physicians, Family; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Social Support; Suicide Prevention

2001
Serotonin agents in the treatment of acquired brain injury.
    The Journal of head trauma rehabilitation, 2002, Volume: 17, Issue:4

    Topics: Brain Injuries; Citalopram; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Injury Severity Score; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2002
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
    Biological psychiatry, 2002, Dec-15, Volume: 52, Issue:12

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride

2002
[Pharmacokinetics and drug interaction of antidepressants and anti-manic drugs].
    Ryoikibetsu shokogun shirizu, 2003, Issue:38

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antimanic Agents; Carbamazepine; Cyclopropanes; Cytochrome P-450 Enzyme System; Drug Interactions; Fluvoxamine; Humans; Isoenzymes; Lithium; Milnacipran; Paroxetine; Selective Serotonin Reuptake Inhibitors; Valproic Acid

2003
[Panic disorder and agoraphobia].
    Ryoikibetsu shokogun shirizu, 2003, Issue:38

    Topics: Agoraphobia; Cognitive Behavioral Therapy; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Reference Standards; Selective Serotonin Reuptake Inhibitors

2003
[The treatment of OCD].
    Ryoikibetsu shokogun shirizu, 2003, Issue:38

    Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Drug Therapy, Combination; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors

2003
[Eating disorders].
    Ryoikibetsu shokogun shirizu, 2003, Issue:38

    Topics: Comorbidity; Feeding and Eating Disorders; Fluvoxamine; Humans; Nutritional Support; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Reference Standards; Selective Serotonin Reuptake Inhibitors; Serotonin

2003
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania

2003
Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:9

    Topics: Autistic Disorder; Citalopram; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

2004
Pharmacological treatments of pathological gambling.
    Journal of gambling studies, 2005,Spring, Volume: 21, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Fluvoxamine; Gambling; Humans; Naltrexone; Outcome Assessment, Health Care; Paroxetine; Piperazines; Research Design; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Triazoles

2005
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
    International journal of clinical practice, 2005, Volume: 59, Issue:12

    Topics: Antidepressive Agents, Second-Generation; Citalopram; Fluoxetine; Fluvoxamine; Humans; Mood Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2005
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:10 Pt 2

    Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted

2006
[Review of pharmacological efficacies and side effects of antidepressants].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Volume: 65, Issue:9

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Fluvoxamine; Humans; Imipramine; Maprotiline; Paroxetine; Sulpiride; Trazodone

2007
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
    Biological psychiatry, 2008, Feb-15, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride

2008
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
    Obstetrics and gynecology, 2008, Volume: 111, Issue:5

    Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2008
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:2 Pt 2

    Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2010
[Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2010, Volume: 30, Issue:2

    Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Fibroblast Growth Factor 2; Fluvoxamine; Forecasting; Humans; Meta-Analysis as Topic; Paroxetine; Pharmacogenetics; Polymorphism, Genetic; Precision Medicine; Racial Groups; Randomized Controlled Trials as Topic; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-2; Serotonin Plasma Membrane Transport Proteins

2010
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    International clinical psychopharmacology, 2010, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult

2010
Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
    Expert review of neurotherapeutics, 2010, Volume: 10, Issue:8

    Topics: Citalopram; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Placebo Effect; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2010
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
    Postgraduate medicine, 2010, Volume: 122, Issue:4

    Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens

2010
[Selective serotonin reuptake inhibitors and mammary pathologies].
    Voprosy onkologii, 2010, Volume: 56, Issue:4

    Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline

2010
[Cardioprotective effect of fluvoxamine, sigma-1 receptor high affinity agonist].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:2

    Topics: Animals; Cardiomegaly; Cardiotonic Agents; Disease Models, Animal; Fluvoxamine; Heart Ventricles; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type III; Paroxetine; Proto-Oncogene Proteins c-akt; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor; Signal Transduction

2012
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Current medicinal chemistry, 2012, Volume: 19, Issue:12

    Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride

2012
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    The Cochrane database of systematic reviews, 2015, 05-01, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride

2015
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.
    The American journal of psychiatry, 2016, Feb-01, Volume: 173, Issue:2

    Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2016
Antidepressant pharmacogenetics in children and young adults: A systematic review.
    Journal of affective disorders, 2019, 07-01, Volume: 254

    Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult

2019
Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Algorithms; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Desvenlafaxine Succinate; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Psychometrics; Sertraline; Treatment Outcome

2020
Recent sample pretreatment methods for determination of selective serotonin reuptake inhibitors (SSRIs) in biological samples.
    Journal of pharmaceutical and biomedical analysis, 2021, Nov-30, Volume: 206

    Topics: Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors

2021
The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Antidepressive Agents; COVID-19 Drug Treatment; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride

2022
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
    Molecular psychiatry, 2023, Volume: 28, Issue:1

    Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine

2023

Trials

37 trial(s) available for paroxetine and fluvoxamine

ArticleYear
The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:6

    Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Drug Administration Schedule; Electrocardiography; Female; Fluvoxamine; Heart Rate; Humans; Male; Middle Aged; Paroxetine

1994
Response to an open trial of a second SSRI in major depression.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:3

    Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    European journal of clinical pharmacology, 1996, Volume: 51, Issue:1

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Caffeine; Chromatography, High Pressure Liquid; Citalopram; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sparteine

1996
Personality disorder scores improve with effective pharmacotherapy of depression.
    Journal of affective disorders, 1997, Volume: 43, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Ergolines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Disorders; Personality Inventory; Serotonin Antagonists

1997
A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:4

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Fluvoxamine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep; Sweating; Treatment Outcome; Xerostomia

1997
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Single-Blind Method

1997
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Journal of sex & marital therapy, 1997,Fall, Volume: 23, Issue:3

    Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires

1997
Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Drug Interactions; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Smoking

1998
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Archives of general psychiatry, 1999, Volume: 56, Issue:4

    Topics: Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Pindolol; Placebos; Selective Serotonin Reuptake Inhibitors; Single-Blind Method

1999
CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:2

    Topics: Adult; Cytochrome P-450 CYP2D6; Dextromethorphan; Dextrorphan; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Reference Values; Sertraline

1999
Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care.
    BMJ (Clinical research ed.), 2000, Jan-01, Volume: 320, Issue:7226

    Topics: Adolescent; Adult; Aged; Algorithms; Antidepressive Agents; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depressive Disorder; Fluvoxamine; Humans; Middle Aged; Paroxetine; Problem Solving; Psychotherapy; Treatment Outcome

2000
Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:5

    Topics: Adult; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires; Time Factors

2000
Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes?
    Psychiatry research, 2000, Sep-25, Volume: 96, Issue:1

    Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome

2000
[What is the "best" treatment of depression in general practice?].
    Presse medicale (Paris, France : 1983), 2000, Oct-28, Volume: 29, Issue:32

    Topics: Adolescent; Adult; Aged; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Family Practice; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Problem Solving; Treatment Outcome

2000
Neurophysiologic tests during antidepressive treatment - an exploratory study.
    Pharmacopsychiatry, 2000, Volume: 33, Issue:6

    Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Autonomic Nervous System; Depressive Disorder, Major; Doxepin; Female; Fluvoxamine; Heart Rate; Humans; Male; Middle Aged; Neural Conduction; Paroxetine; Psychometrics; Reaction Time; Reflex; Selective Serotonin Reuptake Inhibitors

2000
Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:8

    Topics: Adult; Circadian Rhythm; Drug Administration Schedule; Equipment Design; Eyelids; Female; Fluvoxamine; Head; Humans; Longitudinal Studies; Male; Monitoring, Ambulatory; Monitoring, Physiologic; Movement; Paroxetine; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Stages; Sleep, REM; Substance Withdrawal Syndrome

2001
Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients.
    Medical science monitor : international medical journal of experimental and clinical research, 2002, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depression; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Psychotherapeutic Processes; Time Factors; Treatment Outcome

2002
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    The international journal of neuropsychopharmacology, 2002, Volume: 5, Issue:1

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Antimanic Agents; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Female; Fluvoxamine; Genotype; Humans; Lithium; Male; Middle Aged; Monoamine Oxidase; Paroxetine; Pindolol; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sex Characteristics

2002
CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.
    Pharmacotherapy, 2002, Volume: 22, Issue:8

    Topics: Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Fluoxetine; Fluvoxamine; Genotype; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2002
Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2004, Aug-15, Volume: 129B, Issue:1

    Topics: Adult; Analysis of Variance; Chi-Square Distribution; DNA; Double-Blind Method; Drug Therapy, Combination; Female; Fluvoxamine; Gene Frequency; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Mood Disorders; Nerve Tissue Proteins; Paroxetine; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome; Tryptophan Hydroxylase

2004
Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age.
    Human psychopharmacology, 2004, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Chi-Square Distribution; Cohort Studies; Cyclopropanes; Depression; Female; Fluvoxamine; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2004
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10

    Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain

2004
Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    International clinical psychopharmacology, 2005, Volume: 20, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depressive Disorder; Female; Fluvoxamine; Genotype; Heterozygote; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Patient Dropouts; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins

2005
Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism.
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2005, Aug-05, Volume: 137B, Issue:1

    Topics: Adult; Aged; Antidepressive Agents; CLOCK Proteins; Double-Blind Method; Drug Therapy, Combination; Female; Fluvoxamine; Gene Frequency; Genotype; Humans; Male; Middle Aged; Mood Disorders; Multivariate Analysis; Paroxetine; Pindolol; Polymorphism, Genetic; Serotonin Antagonists; Sleep Initiation and Maintenance Disorders; Time Factors; Trans-Activators; Treatment Outcome

2005
T3 augmentation of SSRI resistant depression.
    Journal of affective disorders, 2006, Volume: 91, Issue:2-3

    Topics: Adult; Aged; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Resistance; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Triiodothyronine

2006
Phenytoin as an augmentation for SSRI failures: a small controlled study.
    Journal of affective disorders, 2006, Volume: 96, Issue:1-2

    Topics: Adult; Aged; Anticonvulsants; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Phenytoin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2006
Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
    Journal of psychosomatic research, 2007, Volume: 62, Issue:2

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Fluvoxamine; Humans; Meditation; Paroxetine; Program Development; Self Care; Sertraline; Stress, Psychological; Surveys and Questionnaires

2007
Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Journal of medicine, 2004, Volume: 35, Issue:1-6

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors

2004
A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:6

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Fluvoxamine; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult

2009
Clinical features and treatment characteristics of compulsive hoarding in Japanese patients with obsessive-compulsive disorder.
    CNS spectrums, 2010, Volume: 15, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Compulsive Behavior; Female; Fluvoxamine; Humans; Japan; Male; Obsessive-Compulsive Disorder; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult

2010
The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine.
    European journal of clinical pharmacology, 2012, Volume: 68, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Fluvoxamine; Genetic Association Studies; Half-Life; Humans; Japan; Male; Metabolic Clearance Rate; Paroxetine; Piperazines; Polymorphism, Genetic; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Young Adult

2012
Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
    Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:2

    Topics: Adolescent; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Drug Interactions; Female; Fluvoxamine; Half-Life; Humans; Intestine, Small; Liver; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Terfenadine; Young Adult

2012
Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.
    Progress in neuro-psychopharmacology & biological psychiatry, 2012, Aug-07, Volume: 38, Issue:2

    Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Administration Schedule; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Severity of Illness Index; Treatment Outcome

2012
5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:1

    Topics: Analysis of Variance; Antidepressive Agents; Depression; Female; Fluvoxamine; Gene Frequency; Genotype; Humans; Japan; Logistic Models; Male; Paroxetine; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Serotonin Plasma Membrane Transport Proteins; Time Factors; Treatment Outcome

2013
Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs.
    Translational psychiatry, 2015, Feb-24, Volume: 5

    Topics: Age Factors; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclopropanes; Depressive Disorder, Major; Female; Fibroblast Growth Factors; Fluvoxamine; Humans; Japan; Male; Middle Aged; Milnacipran; Paroxetine; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-2; Serotonin Plasma Membrane Transport Proteins; Sex Factors; Treatment Outcome

2015
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Volume: 121, Issue:12

    Topics: Alcoholism; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2021

Other Studies

147 other study(ies) available for paroxetine and fluvoxamine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Inhibition of P-glycoprotein by newer antidepressants.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1

    Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection

2003
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
    Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19

    Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution

2011
Species independence in brain tissue binding using brain homogenates.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7

    Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity

2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine.
    European journal of medicinal chemistry, 2021, Aug-05, Volume: 220

    Topics: Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Ligands; Models, Molecular; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship

2021
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
    British journal of clinical pharmacology, 1992, Volume: 34, Issue:3

    Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sparteine

1992
Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake.
    Molecular pharmacology, 1995, Volume: 48, Issue:4

    Topics: Amino Acid Sequence; Animals; Antidepressive Agents, Second-Generation; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cerebral Cortex; Cyclohexanols; Cytosol; Fluvoxamine; Hippocampus; Male; Molecular Sequence Data; Neurotransmitter Uptake Inhibitors; Norepinephrine; Paroxetine; Phosphorylation; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Synaptosomes; Time Factors; Venlafaxine Hydrochloride

1995
The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
    British journal of pharmacology, 1993, Volume: 110, Issue:1

    Topics: 1-Naphthylamine; Animals; Appetite Depressants; Brain Chemistry; Eating; Fluoxetine; Fluvoxamine; Hydroxyindoleacetic Acid; Indoles; Male; Paroxetine; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline

1993
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    European journal of pharmacology, 1994, Nov-03, Volume: 264, Issue:3

    Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes

1994
Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:2

    Topics: Alprazolam; Biotransformation; Culture Techniques; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Dose-Response Relationship, Drug; Fluvoxamine; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors

1995
Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning.
    European journal of pharmacology, 1995, Mar-06, Volume: 275, Issue:2

    Topics: Analysis of Variance; Animals; Conditioning, Psychological; Disease Models, Animal; Drug Administration Schedule; Fluvoxamine; Injections, Subcutaneous; Male; Morphine; Naloxone; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome; Substance-Related Disorders

1995
[Antidepressive agents with only few serious adverse effects].
    Lakartidningen, 1993, Oct-13, Volume: 90, Issue:41

    Topics: Antidepressive Agents; Drug Interactions; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors

1993
Serotonin syndrome and fluvoxamine: a case study.
    The Nebraska medical journal, 1996, Volume: 81, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors; Syndrome; Time Factors

1996
Potential withdrawal syndrome associated with SSRI discontinuation.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:12

    Topics: 1-Naphthylamine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome

1995
Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro.
    Japanese journal of pharmacology, 1996, Volume: 71, Issue:4

    Topics: Animals; Binding, Competitive; Blood Platelets; Brain; Cerebral Cortex; Fluvoxamine; In Vitro Techniques; Ketanserin; Macaca; Male; Paroxetine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin

1996
Serotonin reuptake inhibitor withdrawal.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5

    Topics: 1-Naphthylamine; Adolescent; Adult; Age Factors; Clomipramine; Dizziness; Female; Fluvoxamine; Humans; Male; Middle Aged; Paresthesia; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Substance Withdrawal Syndrome

1996
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
    International clinical psychopharmacology, 1996, Volume: 11, Issue:3

    Topics: 1-Naphthylamine; Aged; Anorexia; Antidepressive Agents; Depressive Disorder; Diarrhea; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Nausea; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method

1996
[Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands].
    Nederlands tijdschrift voor geneeskunde, 1996, Sep-07, Volume: 140, Issue:36

    Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Belgium; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Netherlands; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Effects of antidepressants on the cytochrome P450 system.
    The American journal of psychiatry, 1996, Volume: 153, Issue:12

    Topics: 1-Naphthylamine; Antidepressive Agents; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Medical Records; Paroxetine; Research Design; Sertraline

1996
A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    British journal of clinical pharmacology, 1996, Volume: 42, Issue:6

    Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome

1996
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
    Psychopharmacology, 1997, Volume: 129, Issue:3

    Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal

1997
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat.
    Journal of psychopharmacology (Oxford, England), 1997, Volume: 11, Issue:1

    Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline

1997
Vitamin C for paroxetine- and fluvoxamine-associated bleeding.
    The American journal of psychiatry, 1997, Volume: 154, Issue:6

    Topics: Adult; Ascorbic Acid; Ecchymosis; Female; Fluvoxamine; Hemorrhage; Humans; Menorrhagia; Panic Disorder; Paroxetine

1997
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    British journal of clinical pharmacology, 1997, Volume: 43, Issue:6

    Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride

1997
The degree of inhibition of dopaminergic neurons in the ventral tegmental area induced by selective serotonin reuptake inhibitors is a function of the density-power-spectrum of the interspike interval.
    Neuroscience, 1997, Volume: 79, Issue:4

    Topics: 1-Naphthylamine; Animals; Dopamine; Dose-Response Relationship, Drug; Fluvoxamine; Male; Membrane Potentials; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Tegmentum Mesencephali

1997
Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
    JAMA, 1998, Feb-25, Volume: 279, Issue:8

    Topics: 1-Naphthylamine; Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Cohort Studies; Female; Fluvoxamine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Caffeine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Female; Fluvoxamine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors

1998
Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors.
    JAMA, 1998, Jun-17, Volume: 279, Issue:23

    Topics: 1-Naphthylamine; Antidepressive Agents; Female; Fluvoxamine; Humans; Paroxetine; Pregnancy; Pregnancy Outcome; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
    European journal of clinical pharmacology, 1998, Volume: 54, Issue:3

    Topics: 1-Naphthylamine; Adult; Anti-Arrhythmia Agents; Child; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Kinetics; Male; Methylation; Metoprolol; Microsomes, Liver; Oxidation-Reduction; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
    Psychopharmacology, 1998, Volume: 138, Issue:2

    Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming

1998
Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
    Brain research bulletin, 1998, Volume: 46, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Fluvoxamine; Male; Membrane Potentials; Neurons; Paroxetine; Propanolamines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Ventral Tegmental Area

1998
[Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].
    Ugeskrift for laeger, 1998, Dec-07, Volume: 160, Issue:50

    Topics: Adult; Antidepressive Agents; Citalopram; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome

1998
Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:12

    Topics: Adolescent; Adult; Child; Citalopram; Cytochrome P-450 Enzyme System; Drug Prescriptions; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Evaluating the tolerability of the newer antidepressants.
    The Journal of nervous and mental disease, 1999, Volume: 187, Issue:2

    Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride

1999
Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Alcohol (Fayetteville, N.Y.), 1999, Volume: 17, Issue:3

    Topics: Alcohol Drinking; Alcoholism; Animals; Citalopram; Disease Models, Animal; Eating; Ethanol; Female; Fluoxetine; Fluvoxamine; Food Preferences; Male; Paroxetine; Rats; Rats, Mutant Strains; Selective Serotonin Reuptake Inhibitors

1999
Excretion of paroxetine into breast milk.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:8

    Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides

1999
[Severe withdrawal symptoms with fever upon stopping paroxetine].
    Nederlands tijdschrift voor geneeskunde, 1999, Aug-28, Volume: 143, Issue:35

    Topics: Citalopram; Drug Administration Schedule; Fever; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome

1999
Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999, Dec-01, Volume: 19, Issue:23

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Carrier Proteins; Desipramine; Fluvoxamine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Paroxetine; Phenelzine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Time Factors

1999
Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography.
    Therapeutic drug monitoring, 2000, Volume: 22, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluorometry; Fluoxetine; Fluvoxamine; Humans; Linear Models; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline

2000
[Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine].
    Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2000, Volume: 28, Issue:2

    Topics: Antidepressive Agents, Tricyclic; Child; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tics; Tourette Syndrome; Treatment Outcome; Trimipramine

2000
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:10

    Topics: Antibodies; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Paroxetine; Piperazines; Sertraline; Triazoles

2000
Modification of presynaptic CaM kinase II affinity for ATP in hippocampus after long term blockade of serotonin reuptake.
    Life sciences, 2000, Sep-08, Volume: 67, Issue:16

    Topics: Adenosine Triphosphate; Animals; Antidepressive Agents, Second-Generation; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Fluvoxamine; Hippocampus; Kinetics; Male; Paroxetine; Phosphorylation; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors

2000
Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.
    Clinical therapeutics, 2001, Volume: 23, Issue:2

    Topics: Adult; Antidepressive Agents; Cross-Sectional Studies; Drug Costs; Fluoxetine; Fluvoxamine; Forecasting; Humans; Insurance Claim Reporting; Insurance, Pharmaceutical Services; Middle Aged; Models, Theoretical; Ontario; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2001
SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects.
    Journal of sleep research, 2001, Volume: 10, Issue:2

    Topics: Adult; Dreams; Female; Fluvoxamine; Humans; Male; Mental Recall; Paroxetine; Periodicity; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sleep, REM; Surveys and Questionnaires

2001
[The transfer of selective serotonin reuptake inhibitors to human milk].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2001, Jan-20, Volume: 121, Issue:2

    Topics: Antidepressive Agents; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Milk, Human; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2001
Use of sertraline, paroxetine and fluvoxamine by nursing women.
    The British journal of psychiatry : the journal of mental science, 2001, Volume: 179

    Topics: Breast Feeding; Chromatography, High Pressure Liquid; Depression, Postpartum; Female; Fluvoxamine; Humans; Infant, Newborn; Paroxetine; Regression Analysis; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline

2001
Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire international, 1999, Volume: 8, Issue:43

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1999
The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
    British journal of pharmacology, 2001, Volume: 134, Issue:1

    Topics: Animals; Binding, Competitive; Body Temperature; Brain; Cerebral Cortex; Fluoxetine; Fluvoxamine; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Neuroprotective Agents; Paroxetine; Rats; Rectum; Serotonin; Serotonin Agents; Time Factors; Tritium

2001
Clinical predictors of drug response in obsessive-compulsive disorder.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:5

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Citalopram; Clomipramine; Drug Resistance; Female; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Psychological Tests; Random Allocation; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2001
No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors.
    Psychiatry research, 2001, Nov-30, Volume: 104, Issue:3

    Topics: Depressive Disorder, Major; Exons; Female; Fluvoxamine; Gene Expression; Gene Frequency; Humans; Male; Middle Aged; Paroxetine; Receptors, Dopamine D2; Receptors, Dopamine D4; Selective Serotonin Reuptake Inhibitors

2001
SSRIs associated with behavioral activation and suicidal ideation.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:12

    Topics: Attention Deficit and Disruptive Behavior Disorders; Child; Depressive Disorder, Major; Fluvoxamine; Humans; Male; Paroxetine; Suicide, Attempted

2001
The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment.
    Psychopharmacology, 2002, Volume: 160, Issue:3

    Topics: Animals; Ejaculation; Female; Fluvoxamine; Male; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sexual Behavior, Animal

2002
The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    European journal of pharmacology, 2002, Mar-29, Volume: 439, Issue:1-3

    Topics: Animals; Dose-Response Relationship, Drug; Extracellular Space; Fluvoxamine; Genotype; Hippocampus; Injections, Intraperitoneal; Mice; Mice, Inbred Strains; Mice, Knockout; Microdialysis; Paroxetine; Pyridines; Pyrroles; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Time Factors

2002
Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2002, Volume: 366, Issue:2

    Topics: Antidepressive Agents; Cells, Cultured; Chloride Channels; Citalopram; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluvoxamine; Humans; Hydrogen-Ion Concentration; Hypotonic Solutions; Inhibitory Concentration 50; Membrane Potentials; Paroxetine; Patch-Clamp Techniques; Pulmonary Artery; Selective Serotonin Reuptake Inhibitors; Sertraline

2002
Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine.
    European journal of pharmacology, 2002, Nov-15, Volume: 454, Issue:2-3

    Topics: Animals; Antidepressive Agents; Avoidance Learning; Cholinergic Antagonists; Clomipramine; Defecation; Fluvoxamine; Immobilization; Mice; Mice, Inbred ICR; Paroxetine; Selective Serotonin Reuptake Inhibitors

2002
Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.
    Psychiatric services (Washington, D.C.), 2003, Volume: 54, Issue:2

    Topics: Citalopram; Clinical Pharmacy Information Systems; Cost Control; Cost Savings; Drug Administration Schedule; Drug Costs; Drug Utilization; Fluoxetine; Fluvoxamine; Hospital Costs; Hospitals, Veterans; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States

2003
Drug-related hyperprolactinemia.
    Prescrire international, 2003, Volume: 12, Issue:63

    Topics: Antidepressive Agents; Antipsychotic Agents; Female; Flunarizine; Fluoxetine; Fluvoxamine; Humans; Hyperprolactinemia; Indoramin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sulpiride

2003
Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.
    Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:1

    Topics: Adult; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Skin

2003
Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression.
    Human psychopharmacology, 2003, Volume: 18, Issue:6

    Topics: Antidepressive Agents; Bipolar Disorder; Cyclopropanes; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Milnacipran; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Time Factors; Treatment Outcome

2003
[Anxiety in school refusal children with indefinite complaints: psychological estimation using State-Trait Anxiety Inventory and therapy by serotonin reuptake inhibitors].
    No to hattatsu = Brain and development, 2003, Volume: 35, Issue:5

    Topics: Adolescent; Anxiety; Child; Female; Fluvoxamine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Student Dropouts; Treatment Outcome

2003
Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    European psychiatry : the journal of the Association of European Psychiatrists, 2003, Volume: 18, Issue:8

    Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cohort Studies; Cyclopropanes; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Personality Inventory; Psychometrics; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome

2003
Different effects of selective serotonin reuptake inhibitors on a patient suffering from panic disorder.
    Human psychopharmacology, 2004, Volume: 19, Issue:1

    Topics: Adult; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Hypnotics and Sedatives; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors

2004
The effects of selective serotonin-reuptake inhibitor on visual evoked potential in rats.
    Journal of pharmacological sciences, 2004, Volume: 94, Issue:3

    Topics: Administration, Oral; Animals; Data Display; Evoked Potentials, Visual; Fluvoxamine; Male; Occipital Lobe; Oscillometry; Paroxetine; Photic Stimulation; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques

2004
A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection.
    Journal of analytical toxicology, 2004, Volume: 28, Issue:3

    Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chromatography, Gas; Chromatography, Liquid; Citalopram; Doxepin; Female; Fluvoxamine; Humans; Mianserin; Nitrogen; Paroxetine; Phosphorus; Reproducibility of Results; Trazodone

2004
'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam.
    Behavioural pharmacology, 2004, Volume: 15, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Compulsive Behavior; Conditioning, Operant; Desipramine; Diazepam; Dose-Response Relationship, Drug; Extinction, Psychological; Fluvoxamine; Male; Paroxetine; Rats; Rats, Wistar; Reward; Selective Serotonin Reuptake Inhibitors

2004
Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire international, 2004, Volume: 13, Issue:71

    Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline

2004
Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 78, Issue:4

    Topics: Animals; Brain; Dose-Response Relationship, Drug; Fluvoxamine; Hypokinesia; Male; Motor Activity; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists

2004
Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5

    Topics: Activities of Daily Living; Acute Disease; Ambulatory Care; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Costs; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2004
Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.
    Environmental toxicology and chemistry, 2004, Volume: 23, Issue:9

    Topics: Animals; Citalopram; Cladocera; Ecosystem; Female; Fluoxetine; Fluvoxamine; Lethal Dose 50; Male; No-Observed-Adverse-Effect Level; Paroxetine; Reproduction; Selective Serotonin Reuptake Inhibitors; Sertraline; Toxicity Tests, Acute; Toxicity Tests, Chronic; Water Pollutants, Chemical

2004
In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
    Life sciences, 2004, Oct-29, Volume: 75, Issue:24

    Topics: Analysis of Variance; Animals; Area Under Curve; Binding Sites; Brain; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Paroxetine; Radioligand Assay; Receptors, Serotonin; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Tritium

2004
Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression.
    European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:7

    Topics: Cohort Studies; Cyclopropanes; Depression; Drug Administration Schedule; Fluvoxamine; Humans; Milnacipran; Paroxetine; Psychomotor Agitation; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires

2004
Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    British journal of pharmacology, 2005, Volume: 144, Issue:5

    Topics: Animals; Behavior, Animal; Binding Sites; Brain; Fluoxetine; Fluvoxamine; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Motor Activity; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline

2005
Improvement of dry mouth by replacing paroxetine with fluvoxamine.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:3

    Topics: Aged; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Paroxetine; Receptors, Muscarinic; Selective Serotonin Reuptake Inhibitors; Xerostomia

2005
Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
    Psychopharmacology, 2005, Volume: 179, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Ejaculation; Female; Fluvoxamine; Male; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sexual Behavior, Animal

2005
Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations.
    Progress in neuro-psychopharmacology & biological psychiatry, 2006, Volume: 30, Issue:1

    Topics: Adult; Antipsychotic Agents; Carbon Isotopes; Chromatography, High Pressure Liquid; Clozapine; Computer Simulation; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Fluvoxamine; Humans; Male; Paroxetine; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Time Factors

2006
Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2006, Volume: 16, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Radiation; Drug Interactions; Fluvoxamine; Inhibition, Psychological; Male; Maze Learning; Paroxetine; Rats; Rats, Wistar; Reaction Time; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Sexual Behavior, Animal; Swimming

2006
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride

2005
Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.
    Journal of affective disorders, 2006, Volume: 90, Issue:2-3

    Topics: Antidepressive Agents, Second-Generation; Biological Availability; Catechol O-Methyltransferase; Citalopram; Depressive Disorder, Major; Dopamine; Ethnicity; Female; Fluvoxamine; Follow-Up Studies; Frontal Lobe; Genetic Carrier Screening; Genotype; Humans; Male; Methionine; Paroxetine; Personality Inventory; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Valine

2006
Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors.
    Brain research, 2006, Jan-05, Volume: 1067, Issue:1

    Topics: Animals; Corticosterone; Fluvoxamine; Ketanserin; Paroxetine; Rats; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors

2006
Effect of paroxetine on marble-burying behavior in mice.
    Methods and findings in experimental and clinical pharmacology, 2005, Volume: 27, Issue:10

    Topics: Animals; Clomipramine; Dose-Response Relationship, Drug; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors

2005
Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.
    Journal of chromatography. A, 2006, May-19, Volume: 1115, Issue:1-2

    Topics: Calibration; Chemical Fractionation; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Fluvoxamine; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sewage; Water Pollutants, Chemical

2006
Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.
    Neuropsychobiology, 2006, Volume: 53, Issue:4

    Topics: Adult; Antidepressive Agents; Chi-Square Distribution; Depression; Dose-Response Relationship, Drug; Female; Fluvoxamine; Humans; Japan; Male; Middle Aged; Paroxetine; Receptors, Serotonin, 5-HT2; Retrospective Studies; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index

2006
Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
    Fukushima journal of medical science, 2006, Volume: 52, Issue:1

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Fluvoxamine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Spinal Cord Injuries

2006
Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.
    Psychiatry research, 2007, Jan-15, Volume: 154, Issue:1

    Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia; Benzodiazepines; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Energy Metabolism; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Net; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Prefrontal Cortex; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2007
Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran.
    Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 375, Issue:1

    Topics: Adrenal Medulla; Animals; Antidepressive Agents; Butadienes; Catecholamines; Cattle; Cells, Cultured; Cyclopropanes; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Enzyme Activation; Fluvoxamine; Milnacipran; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Paroxetine; Phosphorylation; Protein Kinase Inhibitors; Selective Serotonin Reuptake Inhibitors; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase

2007
Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.
    European journal of pharmacology, 2007, Jun-01, Volume: 563, Issue:1-3

    Topics: Animals; Behavior, Animal; Brain; Butyrates; Disease Models, Animal; Dose-Response Relationship, Drug; Ethylenediamines; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Morpholines; Obsessive-Compulsive Disorder; Paroxetine; Phenazocine; Piperazines; Psychotropic Drugs; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor; Tropanes

2007
Antidepressant response in the elderly.
    Psychiatry research, 2007, Jul-30, Volume: 152, Issue:1

    Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2007
Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder.
    Sleep medicine, 2008, Volume: 9, Issue:3

    Topics: Aged; Female; Fluvoxamine; Humans; Isoindoles; Paroxetine; Piperazines; Polysomnography; Pyrimidines; Reaction Time; REM Sleep Behavior Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sleep, REM; Treatment Outcome

2008
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503.
    Biological psychiatry, 2007, Oct-15, Volume: 62, Issue:8

    Topics: Adult; Brain; Dose-Response Relationship, Drug; Fluvoxamine; Humans; Male; Paroxetine; Piperazines; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor

2007
Patient satisfaction with antidepressants: an Internet-based study.
    Journal of affective disorders, 2008, Volume: 107, Issue:1-3

    Topics: Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclopropanes; Data Collection; Depressive Disorder, Major; Fluvoxamine; Humans; Internet; Japan; Logistic Models; Milnacipran; Paroxetine; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires

2008
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    The Journal of clinical psychiatry, 2007, Volume: 68, Issue:10

    Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2007
Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice.
    European journal of pharmacology, 2008, Jan-28, Volume: 579, Issue:1-3

    Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Fluvoxamine; Hot Flashes; Humans; Menopause; Mice; Mice, Inbred ICR; Models, Animal; Ovariectomy; Paroxetine; Physical Conditioning, Animal; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Tail

2008
Shortened protocol in practical [11C]SA4503-PET studies for sigma1 receptor quantification.
    Annals of nuclear medicine, 2008, Volume: 22, Issue:2

    Topics: Adult; Brain Chemistry; Brain Mapping; Carbon Radioisotopes; Clinical Protocols; Fluvoxamine; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Isotope Labeling; Male; Paroxetine; Piperazines; Positron-Emission Tomography; Radioligand Assay; Radiopharmaceuticals; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Tissue Distribution

2008
Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, May-15, Volume: 32, Issue:4

    Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Fluvoxamine; Genotype; Heterotrimeric GTP-Binding Proteins; Humans; Japan; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors

2008
[Psychopharmacological treatment and quality of life in obsessive compulsive disorder].
    Turk psikiyatri dergisi = Turkish journal of psychiatry, 2008,Spring, Volume: 19, Issue:1

    Topics: Adult; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2008
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 2

    Topics: Adult; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Paroxetine

2009
Effects of intrathecal administration of newer antidepressants on mechanical allodynia in rat models of neuropathic pain.
    Neuroscience research, 2009, Volume: 63, Issue:1

    Topics: Analgesics; Animals; Antidepressive Agents; Cyclopropanes; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Fluvoxamine; Hyperalgesia; Injections, Spinal; Male; Milnacipran; Pain Threshold; Paroxetine; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Selective Serotonin Reuptake Inhibitors; Serotonin; Spinal Cord

2009
Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.
    Biological psychiatry, 2009, May-01, Volume: 65, Issue:9

    Topics: Animals; Drugs, Chinese Herbal; Eating; Fenfluramine; Fluoxetine; Fluvoxamine; Gastrointestinal Motility; Ghrelin; Growth Hormone; Injections, Intraventricular; Male; Oligopeptides; Paroxetine; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Ghrelin; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists

2009
Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.
    Acta dermato-venereologica, 2009, Volume: 89, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chronic Disease; Dermatitis, Atopic; Female; Fluvoxamine; Humans; Lymphoma; Male; Middle Aged; Paroxetine; Prospective Studies; Pruritus; Selective Serotonin Reuptake Inhibitors

2009
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.
    The American journal of psychiatry, 2009, Volume: 166, Issue:5

    Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder; Diabetes Mellitus; Female; Fluvoxamine; Humans; Incidence; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; United Kingdom; Venlafaxine Hydrochloride

2009
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
    Psychiatry research, 2009, May-15, Volume: 167, Issue:1-2

    Topics: Adult; Antidepressive Agents; Asian People; Depressive Disorder; Depressive Disorder, Major; Female; Fluvoxamine; Gene Frequency; Genetic Variation; Genotype; Humans; Italy; Male; Middle Aged; Paroxetine; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; White People

2009
Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief.
    Molecular pain, 2009, Apr-23, Volume: 5

    Topics: Action Potentials; Animals; Antidepressive Agents; Cell Line, Tumor; Citalopram; Disease Models, Animal; Fluvoxamine; Humans; Injections, Spinal; Male; Pain; Pain Measurement; Paroxetine; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2X4; Serotonin Antagonists; Spinal Cord

2009
Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.
    Neuroscience letters, 2009, May-01, Volume: 454, Issue:3

    Topics: Animals; Dopamine; Fluoxetine; Fluvoxamine; Haloperidol; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Vesicular Monoamine Transport Proteins

2009
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
    Neuroscience research, 2009, Volume: 64, Issue:3

    Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger

2009
HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
    Neuromolecular medicine, 2010, Volume: 12, Issue:3

    Topics: Asian People; Depressive Disorder, Major; Fluvoxamine; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Paroxetine; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2010
Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study.
    Ophthalmology, 2010, Volume: 117, Issue:6

    Topics: Aged; Case-Control Studies; Cataract; Cataract Extraction; Cyclohexanols; Female; Fluvoxamine; Humans; Male; Paroxetine; Pharmacoepidemiology; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2010
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Pediatrics, 2010, Volume: 125, Issue:5

    Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Suicide Prevention; Suicide, Attempted

2010
Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
    Archives of general psychiatry, 2010, Volume: 67, Issue:5

    Topics: Adult; Aged; Antidepressive Agents; British Columbia; Cause of Death; Citalopram; Cohort Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted

2010
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
    Journal of affective disorders, 2011, Volume: 130, Issue:1-2

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride

2011
Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:5

    Topics: Animals; Aorta; Cells, Cultured; Fluvoxamine; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred ICR; Models, Animal; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Paroxetine; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor; Time Factors; Vasoconstriction; Ventricular Dysfunction, Left

2010
Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.
    European journal of pharmacology, 2010, Nov-25, Volume: 647, Issue:1-3

    Topics: Animals; Corpus Striatum; Dopamine; Extracellular Space; Fluvoxamine; Male; Microdialysis; Norepinephrine; Nucleus Accumbens; Paroxetine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline

2010
Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depression.
    Human psychopharmacology, 2010, Volume: 25, Issue:7-8

    Topics: Adult; Depression; Depressive Disorder; Drug Substitution; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome; Young Adult

2010
Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population.
    Journal of affective disorders, 2011, Volume: 133, Issue:1-2

    Topics: Adult; Asian People; Case-Control Studies; Circadian Clocks; Depressive Disorder, Major; Endopeptidases; Female; Fluvoxamine; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Paroxetine; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Ubiquitin

2011
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2011, Nov-08, Volume: 183, Issue:16

    Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine

2011
Comorbid social withdrawal (hikikomori) in outpatients with social anxiety disorder: clinical characteristics and treatment response in a case series.
    The International journal of social psychiatry, 2013, Volume: 59, Issue:1

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclopropanes; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluvoxamine; Humans; Interview, Psychological; Japan; Male; Milnacipran; Obsessive-Compulsive Disorder; Paroxetine; Phobic Disorders; Psychotherapy, Group; Reactive Attachment Disorder; Retrospective Studies; Social Isolation; Treatment Outcome; Young Adult

2013
Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems.
    European journal of pharmacology, 2011, Dec-15, Volume: 672, Issue:1-3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Neurons; Animals; Antidepressive Agents; Behavior, Animal; Dose-Response Relationship, Drug; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Prazosin; Receptors, Serotonin; Serotonergic Neurons; Serotonin Antagonists; Species Specificity; Swimming; Time Factors

2011
Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?
    International clinical psychopharmacology, 2012, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Citalopram; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Israel; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Paroxetine; Patient Selection; Personality Assessment; Predictive Value of Tests; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult

2012
Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.
    Psychiatry research, 2012, Aug-15, Volume: 198, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Asian People; Cohort Studies; Cyclopropanes; Depressive Disorder, Major; Female; Fluvoxamine; Genome-Wide Association Study; Genotype; GPI-Linked Proteins; Humans; Male; Middle Aged; Milnacipran; Neural Cell Adhesion Molecules; Paroxetine; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological

2012
Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine.
    European journal of pharmacology, 2012, Dec-05, Volume: 696, Issue:1-3

    Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Fluvoxamine; Male; Mice; Mice, Inbred DBA; Motor Activity; Paroxetine; Receptors, sigma; Sigma-1 Receptor; Swimming

2012
The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.
    Paediatric drugs, 2013, Volume: 15, Issue:4

    Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Canada; Child; Child, Preschool; Citalopram; Databases, Factual; Fluoxetine; Fluvoxamine; Humans; Infant; Mental Disorders; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Sertraline

2013
Stimulation of Sigma-1 Receptor Ameliorates Depressive-like Behaviors in CaMKIV Null Mice.
    Molecular neurobiology, 2015, Volume: 52, Issue:3

    Topics: Adenosine Triphosphate; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; CA3 Region, Hippocampal; Calbindins; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Dentate Gyrus; Depression; Fluvoxamine; Gene Expression Regulation; Immobilization; Long-Term Potentiation; Male; Maze Learning; Mice; Mice, Knockout; Nerve Tissue Proteins; Neurogenesis; Paroxetine; Phosphorylation; Piperazines; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Sigma-1 Receptor

2015
Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients.
    Therapeutic drug monitoring, 2015, Volume: 37, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Child; Citalopram; Databases, Factual; Drug Monitoring; Drug Utilization; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult

2015
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
    Journal of affective disorders, 2015, Jul-15, Volume: 180

    Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2015
Pharmacological profile of encounter-induced hyperactivity in isolation-reared mice.
    Behavioural pharmacology, 2015, Volume: 26, Issue:7 Spec No

    Topics: Animals; Animals, Outbred Strains; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Desipramine; Duloxetine Hydrochloride; Fluvoxamine; Hydroxycorticosteroids; Idazoxan; Indoles; Male; Mice; Motor Activity; Neuropsychological Tests; Oxazines; Paroxetine; Piperazines; Psychotropic Drugs; Pyridines; Risperidone; Ritanserin; Social Behavior; Social Isolation; Sulfonamides; Venlafaxine Hydrochloride

2015
Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
    Toxicology in vitro : an international journal published in association with BIBRA, 2015, Volume: 29, Issue:7

    Topics: Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Citalopram; Estradiol; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Progesterone; Selective Serotonin Reuptake Inhibitors; Sertraline; Testosterone

2015
Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells.
    Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:9

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Survival; Citalopram; Cyclopropanes; Duloxetine Hydrochloride; Fluvoxamine; Hep G2 Cells; Humans; Liver Neoplasms; Milnacipran; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline

2015
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
    Psychiatry research, 2016, Oct-30, Volume: 244

    Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride

2016
Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications.
    Clinical toxicology (Philadelphia, Pa.), 2017, Volume: 55, Issue:5

    Topics: Child; Child, Preschool; Citalopram; Coma; Dose-Response Relationship, Drug; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Hospitalization; Humans; Infant; Male; Paroxetine; Poison Control Centers; Retrospective Studies; Seizures; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Vilazodone Hydrochloride

2017
Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Adult; Antidepressive Agents; Citalopram; Databases, Factual; Depressive Disorder; Drug Monitoring; Female; Fluvoxamine; Humans; Norway; Paroxetine; Pregnancy; Pregnancy Trimester, Third; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2017
A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Psychopharmacology, 2017, Volume: 234, Issue:20

    Topics: Adult; Aged; Arrhythmias, Cardiac; Citalopram; Databases, Factual; Female; Fluvoxamine; Humans; Long QT Syndrome; Male; Middle Aged; Paroxetine; Pharmacovigilance; Selective Serotonin Reuptake Inhibitors; Sertraline

2017
Antidepressants Rescue Stress-Induced Disruption of Synaptic Plasticity via Serotonin Transporter-Independent Inhibition of L-Type Calcium Channels.
    Biological psychiatry, 2018, 07-01, Volume: 84, Issue:1

    Topics: Age Factors; Animals; Antidepressive Agents; Cadmium Chloride; Calcium Channel Blockers; Calcium Channels, L-Type; CHO Cells; Cricetulus; Disease Models, Animal; Electric Stimulation; Female; Fluvoxamine; HEK293 Cells; Hindlimb Suspension; Hippocampus; Humans; In Vitro Techniques; Male; Membrane Potentials; Nifedipine; Paroxetine; Patch-Clamp Techniques; Piperazines; Pyridines; Rats; Rats, Transgenic; Rats, Wistar; RNA-Binding Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Stress, Psychological; Swimming; Synaptic Transmission; Transfection

2018
Structural basis for recognition of diverse antidepressants by the human serotonin transporter.
    Nature structural & molecular biology, 2018, Volume: 25, Issue:2

    Topics: Antidepressive Agents; Binding Sites; Chemistry, Pharmaceutical; Crystallography, X-Ray; Fluvoxamine; Humans; Kinetics; Mutation; Paroxetine; Protein Binding; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline

2018
Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder.
    Neuropsychobiology, 2019, Volume: 78, Issue:3

    Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Fluvoxamine; Genetic Predisposition to Disease; Genotype; Glycogen Synthase Kinase 3 beta; Hippocampus; Humans; Linkage Disequilibrium; Male; Middle Aged; Paroxetine; Polymorphism, Single Nucleotide

2019
Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
    Chinese medical journal, 2020, Mar-20, Issue:6

    Topics: Antidepressive Agents; Anxiety; Citalopram; Depressive Disorder, Major; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Least-Squares Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2020
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022, 10-19, Volume: 37, Issue:11

    Topics: Case-Control Studies; Citalopram; Cohort Studies; Death, Sudden, Cardiac; Dialysis Solutions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Potassium; Renal Dialysis; Selective Serotonin Reuptake Inhibitors; Sertraline; United States

2022
Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
    Journal of affective disorders, 2022, 12-01, Volume: 318

    Topics: Adolescent; Antipsychotic Agents; Citalopram; Diabetes Mellitus, Type 2; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline

2022
Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort study.
    European journal of clinical pharmacology, 2023, Volume: 79, Issue:5

    Topics: Adult; Bayes Theorem; Cohort Studies; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Fluvoxamine; Hospitalization; Humans; Outpatients; Paroxetine

2023
Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database.
    Scientific reports, 2023, 07-28, Volume: 13, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Fluvoxamine; Humans; Paroxetine; Pharmacovigilance; Rhabdomyolysis; Selective Serotonin Reuptake Inhibitors; United States; United States Food and Drug Administration

2023
Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
    European journal of pharmacology, 1997, Dec-11, Volume: 340, Issue:2-3

    Topics: Antidepressive Agents; Brain; Carrier Proteins; Cell Line; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Symporters; Synaptosomes

1997